Hydroxychloroquine
Back to searchMolecule Structure
Scientific Name
Hydroxychloroquine
Description of the Drug
Hydroxychloroquine is an antimalarial medication used to treat uncomplicated cases of malaria and for chemoprophylaxis in specific regions. Also a disease modifying anti-rheumatic drug (DMARD) indicated for treatment of rheumatoid arthritis and lupus erythematosus.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01611
http://www.drugbank.ca/drugs/DB01611
Brand Name(s)
Not Available
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Senores Pharmaceuticals Inc, Sandoz Inc, Concordia Pharmaceuticals Inc, Watson Laboratories Inc, Laurus Labs Ltd, Ipca Laboratories Ltd, Accord Healthcare Inc, Hikma Pharmaceuticals, Invatech Pharma Solutions Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Toll-like receptor 9 | SINGLE PROTEIN | ANTAGONIST | CHEMBL5804 |
| Ferriprotoporphyrin IX | SMALL MOLECULE | INHIBITOR | CHEMBL613897 |
| Toll-like receptor 7 | SINGLE PROTEIN | ANTAGONIST | CHEMBL5936 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8170 | ||
| PharmGKB | PA164777036 | ||
| Human Metabolome Database | HMDB0015549 | ||
| DrugBank | DB01611 | ||
| PubChem: Thomson Pharma | 14777730 | ||
| PubChem | 3652 | ||
| Mcule | MCULE-6282304706 | ||
| LINCS | LSM-5193 | ||
| Nikkaji | J5.298A | ||
| BindingDB | 50467780 | ||
| EPA CompTox Dashboard | DTXSID8023135 | ||
| DrugCentral | 1395 | ||
| Brenda | 239396 | 38397 | |
| ChemicalBook | CB6866802 | ||
| Guide to Pharmacology | 7198 | ||
| rxnorm | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE SULFATE | PLAQUENIL |
| KEGG Ligand | C07043 | ||
| ChEBI | 5801 |
